Supplemental material
Current Medical Research and Opinion
Volume 36, 2020 - Issue 11
Oncology
The economic impact of disease progression and death in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer patients: using Korean nationwide health insurance claims data
Sun-Kyeong Parka College of Pharmacy, The Catholic University of Korea, Bucheon, Korea;b School of Pharmacy, Sungkyunkwan University, Suwon, KoreaCorrespondence[email protected]
https://orcid.org/0000-0003-4421-4513
https://orcid.org/0000-0003-4421-4513, Jae-A Parkb School of Pharmacy, Sungkyunkwan University, Suwon, Koreahttps://orcid.org/0000-0002-1618-2369
https://orcid.org/0000-0002-1618-2369, So-Young Yangb School of Pharmacy, Sungkyunkwan University, Suwon, Koreahttps://orcid.org/0000-0002-6850-3486
https://orcid.org/0000-0002-6850-3486, Ju-Young Shinb School of Pharmacy, Sungkyunkwan University, Suwon, Koreahttps://orcid.org/0000-0003-1010-7525
https://orcid.org/0000-0003-1010-7525 &